Clinical Trial Detail

NCT ID NCT03598257
Title Radiation Therapy With or Without Olaparib in Treating Participants With Inflammatory Breast Cancer
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors National Cancer Institute (NCI)
Indications

inflammatory breast carcinoma

Therapies

Olaparib

Age Groups: senior adult

No variant requirements are available.